Assessment of the impact of manufacturing changes on the physicochemical properties of the recombinant vaccine carrier ExoProtein A

Efforts to develop a vaccine for the elimination of malaria include the use of carrier proteins to assemble monomeric antigens into nanoparticles to maximize immunogenicity. Recombinant ExoProtein A (EPA) is a detoxified form of Pseudomonas aeruginosa Exotoxin A which has been used as a carrier in t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine
Main Authors: Burkhardt, Martin, Reiter, Karine, Nguyen, Vu, Suzuki, Motoshi, Herrera, Raul, Duffy, Patrick E., Shimp, Richard, MacDonald, Nicholas J., Olano, L. Renee, Narum, David L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6525083/
https://ncbi.nlm.nih.gov/pubmed/30262247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2018.09.037
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados